Jove
Visualize
联系我们

相关概念视频

Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator.

Circulation·2026
Same author

Redox-controlled near-infrared-to-near-infrared optical switching in TPA dimers.

Physical chemistry chemical physics : PCCP·2026
Same author

Crystal structure of tris-[4-(3,4-di-meth-oxy-thio-phen-2-yl)phen-yl]amine.

Acta crystallographica. Section E, Crystallographic communications·2026
Same author

Catecholaminergic polymorphic ventricular tachycardia-linked ryanodine receptor variants exhibit domain-specific calcium leak and calmodulin affinity properties.

The Journal of physiology·2025
Same author

Concurrent Large-vessel Vasculitis and Small-vessel Vasculitis Accompanied by Basal Cell Carcinoma.

Internal medicine (Tokyo, Japan)·2025
Same author

Structural instability of ryanodine receptor 2 causes endoplasmic reticulum (ER) dysfunction as well as sarcoplasmic reticulum (SR) dysfunction.

Journal of cardiology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 6, 2026

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

甲醇通过恢复FKBP12.6介导的氨酸受体稳定性来预防心力衰竭的发展.

Masahiro Doi1, Masafumi Yano, Shigeki Kobayashi

  • 1Department of Medical Bioregulation, Division of Cardiovascular Medicine, Yamaguchi University School of Medicine, Yamaguchi, Japan.

Circulation
|March 20, 2002
PubMed
概括

像普拉诺洛尔这样的β抑制剂可以通过恢复受体 (RyRs) 的功能和它们与FKBP12.6的相互作用来修复心力衰竭中的异常泄漏,从而改善心脏性能.

更多相关视频

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

相关实验视频

Last Updated: Jul 6, 2026

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

科学领域:

  • 心脏病学 心脏病学
  • 分子生物学分子生物学
  • 生物化学 生物化学

背景情况:

  • 心力衰竭与在体网膜 (SR) 中的氨酸受体 (RyRs) 的过酸化有关.
  • 这种高酸化导致FKBP12.6与RyRs解离,导致异常的 (Ca2+) 泄漏和潜在的心脏功能障碍.
  • 贝塔抑制剂正在研究其在心力衰竭中纠正RyR缺陷的潜力.

研究的目的:

  • 为了确定β-阻塞剂是否可以纠正高心率引起的心力衰竭的RyR缺陷.
  • 评估正确的RyR功能对心脏功能和细胞内Ca2+处理的影响.
  • 为了研究β抑制剂影响RyR-FKBP12.6相互作用的分子机制.

主要方法:

  • 在狗的左心室肌肉中产生了高心率诱导的心力衰竭.
  • 普罗普拉诺洛尔用于评估其对SR Ca2+泄漏和RyR功能的影响.
  • 技术包括 [3H]FK506 和 [3H]氨酸结合试验和西部斑分析.

主要成果:

  • 甲醇治疗减弱了心脏尺寸的增加,并保持了分数缩短.
  • 与未经治疗的心脏不同的是,用propranolol治疗心脏的SRs没有显著的Ca2+泄漏.
  • 兰醇恢复了FKBP12.6的固态度和蛋白质表达,并使RyR形状变化正常化.

结论:

  • 低剂量普拉诺洛尔有效地纠正了心力衰竭中缺陷的FKBP12.6-RyR相互作用.
  • 这种纠正可以防止RyRs的异常Ca2+泄漏,减轻细胞内Ca2+过载.
  • 普拉诺洛尔治疗减弱左心室重塑,从而改善心力衰竭中的心脏功能.